Abstract
Objective: We sought to determine the safety and acceptability of vaginal gel formulation PC-503 among low risk, abstinent women. The active ingredient was 2% pharmaceutical grade lambda carrageenan, a sulphated polymer that is generally recognised as safe by the US Food and Drug Administration.
Methods: 35 women in five sites applied 5 ml of the PC-503 gel vaginally once a day for 7 days while abstaining from sexual intercourse. Visual vaginal examinations were performed on days 1, 4, and 8. STI testing and vaginal pool Gram stain preparations were done on days 1 and 8. Participants were asked about product acceptability.
Results: 34 of the 35 women enrolled completed 7 days' use. Following product use, five reported mild symptoms including "bladder fullness," "genital warmth," or discomfort, and lower abdominal pain, and one had moderate pale yellow cervical discharge. Using the Nugent criteria, three women had bacterial vaginosis (BV) before and after use; three had BV before but not after, and two had BV after but not before. Most of the women found PC-503 to be pleasant or neutral in feel and smell and considered extra lubrication to be an advantage; however, one third found it to be messy.
Conclusions: Vaginal use of PC-503 gel did not cause significant adverse effects in a small number of low risk, sexually abstinent women. Further testing in larger numbers of sexually active women is planned. A smaller volume of gel may be more acceptable to some women.
Key Words: microbicide; carrageenan
Full Text
The Full Text of this article is available as a PDF (97.2 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Coggins C., Elias C. J., Atisook R., Bassett M. T., Ettiègnene-Traoré V., Ghys P. D., Jenkins-Woelk L., Thongkrajai E., VanDevanter N. L. Women's preferences regarding the formulation of over-the-counter vaginal spermicides. AIDS. 1998 Jul 30;12(11):1389–1391. doi: 10.1097/00002030-199811000-00022. [DOI] [PubMed] [Google Scholar]
- Elias C. J., Coggins C., Alvarez F., Brache V., Fraser I. S., Lacarra M., Lähteenmäki P., Massai R., Mishell D. R., Jr, Phillips D. M. Colposcopic evaluation of a vaginal gel formulation of iota-carrageenan. Contraception. 1997 Dec;56(6):387–389. doi: 10.1016/s0010-7824(97)00176-5. [DOI] [PubMed] [Google Scholar]
- Elias C. J., Coggins C. Female-controlled methods to prevent sexual transmission of HIV. AIDS. 1996 Dec;10 (Suppl 3):S43–S51. [PubMed] [Google Scholar]
- NAHMIAS A. J., KIBRICK S., BERNFELD P. EFFECT OF SYNTHETIC AND BIOLOGICAL POLYANIONS ON HERPES SIMPLEX VIRUS. Proc Soc Exp Biol Med. 1964 Apr;115:993–996. doi: 10.3181/00379727-115-29098. [DOI] [PubMed] [Google Scholar]
- Nugent R. P., Krohn M. A., Hillier S. L. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol. 1991 Feb;29(2):297–301. doi: 10.1128/jcm.29.2.297-301.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pearce-Pratt R., Phillips D. M. Sulfated polysaccharides inhibit lymphocyte-to-epithelial transmission of human immunodeficiency virus-1. Biol Reprod. 1996 Jan;54(1):173–182. doi: 10.1095/biolreprod54.1.173. [DOI] [PubMed] [Google Scholar]
- Royce R. A., Thorp J., Granados J. L., Savitz D. A. Bacterial vaginosis associated with HIV infection in pregnant women from North Carolina. J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Apr 1;20(4):382–386. doi: 10.1097/00042560-199904010-00009. [DOI] [PubMed] [Google Scholar]
- Sewankambo N., Gray R. H., Wawer M. J., Paxton L., McNaim D., Wabwire-Mangen F., Serwadda D., Li C., Kiwanuka N., Hillier S. L. HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet. 1997 Aug 23;350(9077):546–550. doi: 10.1016/s0140-6736(97)01063-5. [DOI] [PubMed] [Google Scholar]
- Stein Z. A. HIV prevention: the need for methods women can use. Am J Public Health. 1990 Apr;80(4):460–462. doi: 10.2105/ajph.80.4.460. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Taha T. E., Hoover D. R., Dallabetta G. A., Kumwenda N. I., Mtimavalye L. A., Yang L. P., Liomba G. N., Broadhead R. L., Chiphangwi J. D., Miotti P. G. Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS. 1998 Sep 10;12(13):1699–1706. doi: 10.1097/00002030-199813000-00019. [DOI] [PubMed] [Google Scholar]
- Zacharopoulos V. R., Phillips D. M. Vaginal formulations of carrageenan protect mice from herpes simplex virus infection. Clin Diagn Lab Immunol. 1997 Jul;4(4):465–468. doi: 10.1128/cdli.4.4.465-468.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zaretzky F. R., Pearce-Pratt R., Phillips D. M. Sulfated polyanions block Chlamydia trachomatis infection of cervix-derived human epithelia. Infect Immun. 1995 Sep;63(9):3520–3526. doi: 10.1128/iai.63.9.3520-3526.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]